I'l take ownership of those comments posted on Seeking Alpha. I just haven't had the time or inclination to post here on yahoo, until now.
I will say I was VERY impressed by Skanderbeg's comments explaining and justifying the deal. I love the way these guys give you a "direct window" into their thinking process, transparent, and totally straight up. After listening to the earnings CC, I am as enthusiastic about this deal as ever...because I am certain that the financial people at Claude studied all options, six ways to Sunday. And because I am certain that Skanderbeg made DAMN SURE that Marygold is going to be a continued proven winner....and that SSRI's other properties have real and tangible value.
The way I view it, is they are "switching" Claude shareholders from something that was in the 7th innning of a fabulous run, with more "sizzle" to go, into something that will represent the "next stage" for Claude shareholders......entry into an even MORE UNDERPRICED, LARGER miner, with IMPROVED RESULTS that, like Claude, has not been given NEARLY the credit it has deserved for its success at Marygold.
My suspicion is that, once this deal is done, it will be MUCH easier to get the Street to pay attention to the story of a billion or so market cap miner, versus Claude as a stand alone. And that the multiple we are valued at will be expanded accordingly.
In short, I completely trust Claude management. These guys have some of the very HIGHEST integrity I have witnessed in the corporate space....which was just one of the reasons, at one point in my investment "career," I was willing to own 10 million shares of this thing.
Don't second guess management here; SSRI is undervalued in its own right, and it DOESN'T MATTER what SSRI stock does in the short term. What matters is what a "comparative value" for a combined SSRI/CLGRF is to other miners. And on that basis, I would readily say that this should be in the double digits within 6-12 months.